MAIN MENU

BACK

BACK

  • Home

  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
Explore PAREXEL
  • JourneyGO
  • SolutionsGO
  • ExperienceGO
  • Outsourcing ModelsGO
  • Planning
  • Phase I
  • Phase IIa
  • Phase II-III
  • Phase IIIb-IV
  • Post Launch
  • PAREXEL® Biotech
  • Clinical Research
    • Early Phase Services
      • Dedicated Therapeutic Expertise
        • Early Phase and Late Phase integrated study management
      • Patient Populations
      • Strategic Locations
        • Berlin
          • Virtual Tour
        • London
        • Baltimore
          • Facility
          • Virtual Tour
        • Los Angeles
          • Virtual Tour
      • Phase 1, First in Human
        • Ethnobridging for Accelerated Global Drug Development
      • Phase IIa, Proof of Concept
      • Early Product Development
      • Ethnobridging
      • Clinical PK/PD and Pharmacometrics Services
        • Case Study: Safety/Pharmacovigilance #1
        • Case Study: Safety/Pharmacovigilance #2
      • Bioanalytical and Biomarkers
      • Bioequivalence Studies
      • Volunteer to Participate
    • Phase II-III Services
      • Phase III
        • Case Study: Chronic Renal Failure
        • Case Study: Expanded Access Program
        • Case Study: Accelerating development in global COPD trials
      • Feasibility and Enrollment
        • Patient Recruitment
          • Case Study: Pediatric Migraine Patient Recruitment
        • Country and Site Selection
        • Alliance Site Strategy
        • Protocol Optimization
    • Phase IIIb-IV
    • ForeSite™ Clinical Trial Methodology
      • Study Design
      • Study Start-Up
      • Study Execution
    • Global Data Operations
      • Clinical Data Management
      • Biostatistics Services
      • Clinical MetaData Repository (MDR)
    • Medical Writing Solutions
    • Quantitative Clinical Development Services
    • Clinical Trial Supplies & Logistics
      • Global Reach
      • Clinical Trial Supplies
      • Ancillary Supplies
      • Laboratory Logistics and Biological Sample Lifecycle Management Services
      • Randomization and Trial Supply Management
      • Cold Chain Logistics
      • Clinical Trial Supply Chain - Active Tracking
    • Customer Care Services
    • Genomic Medicine Services
    • Clinical Adjudication Services
  • Informatics
    • Clinical Technology
      • Clinical Trial Management System (CTMS)
      • Electronic Data Capture
      • MyTrials® Analytics
      • Perceptive® Cloud
      • Data-Driven Monitoring
    • Patient Technology
      • Randomization and Trial Supply Management
        • Clinical Trial Supplies & Logistics
        • Clinical Trial Supply Chain - Active Tracking
        • ClinPhone RTSM Mobile App
      • Medical Imaging
        • Therapeutic Expertise
          • Oncology Imaging Expertise
            • Criteria Experience
              • 1996 NCI-WG CLL
              • IWCLL 2008
                • Key Topics: IWCLL 2008
                  • Definitions
                  • Usable Criteria to Evaluate
                  • Target Sites of Disease
                  • Non-Target Sites of Disease
                  • Organomegaly
                  • New Lesions
                  • B symptoms
                  • Blood Counts
                  • Bone Marrow
                  • Transformation
                  • Role of Imaging in CLL Clinical Trials
                  • Clinical Data Assessments
              • 1999 IWG-NHL
              • 2007 IWG-NHL
                • Key Topics: 2007 IWG-NHL Assessment Criteria
                  • Definitions
                  • Usable Criteria to Evaluate
                  • Target Sites of Disease
                  • Non-Target Sites of Disease
                  • Organomegaly
                  • New Lesions
                  • Bone Marrow
                  • Other Laboratory Values and Symptoms
                  • Incorporation of FDG-PET
                  • Defining Normal, Abnormal and Measurable
                  • Problem with CRu
              • RECIST
          • Neurology Imaging Expertise
          • Musculoskeletal (MSK) Imaging Expertise
          • Women's Health Imaging Expertise
          • Dermatology Imaging Expertise
          • Gastroenterology Imaging Expertise
          • Ophthalmology Imaging Expertise
          • Volumetric Imaging Expertise
          • Cardiovascular Imaging Expertise
        • Imaging Services
        • Scientific Advisors
        • Consultation
        • Advanced Medical Imaging
          • Cloud-Based Solutions for Sites
      • Patient Sensors
      • Electronic Clinical Outcome Assessments (eCOA)
        • ePRO (electronic Patient Reported Outcomes)
        • Clinical Outcome Assessments Consulting
    • Regulatory Technology
      • Regulatory Information Management
        • LIQUENT InSight®
        • Regulatory Cloud
        • Regulatory Outsourcing Services
    • Clinical Trial Supplies & Logistics
    • Asset Transfer Services
    • PAREXEL's Education Services
      • IMPACT® CTMS Training
      • LIQUENT InSight® Training
        • Training Resources
      • DataLabs® EDC Training
      • Perceptive MyTrials® Training
      • Data-Driven Monitoring Training
      • Certification Programs
      • Training Services
    • Customer Care Services
  • Regulatory
    • Regulatory Strategy & Development Planning
    • Regulatory GMP Compliance
      • Q&A about GCP
      • Strategic Compliance: Data Integrity
    • Regulatory Partnerships
    • Clinical Trial Regulatory Services
    • China Advisory Services
    • IDMP Solutions
      • IDMP Readiness Assessment
      • IDMP Task Force Updates
        • November 2015 Task Force Meeting
  • Access
    • Real World Evidence
      • Late Phase Clinical Operations
        • Late Phase Interventional Trials
        • Observational Research
        • Epidemiology
        • Expanded Access Programs
        • Clinical Outcome Assessment (COA)
          • Case Study: Health Economics
          • Outcomes Research
      • Real World Data Services
    • Drug Safety Services
      • Risk Management / REMS
    • Market Access Consulting
      • Commercial Decision Pathways
      • Evidence Generation
        • Evidence Review and Meta-Analysis
          • Evidence Review Options
          • Evidence Review Resources
        • Health Economic Modeling
        • Global and AMCP Value Dossiers
        • Manuscripts and Posters
        • Data Analytics
        • Strategic Communications
      • Access Realization
        • Pricing, Reimbursement and Market Access Expertise
        • List of Services: Pricing, Reimbursement and Market Access
    • Medical Communications
      • Communication Strategy
      • Publications Planning and Scientific Content
      • Expert Identification and Engagement
      • Global Study Engagement
      • Branding and Creative Strategy
      • Digital Media and Video Solutions
      • Live and Virtual Events
      • Payer Communication
      • Editorial and Production
    • Outsourced Field-Based Medical Teams
  • Therapeutic Expertise
    • Oncology
    • Cardiovascular & Metabolic Diseases
    • Central Nervous System (CNS) Disorders
    • Infectious Disease
    • Respiratory Capabilities
    • Rheumatology & Immunology Capabilities
    • Rare Diseases
  • Patient Innovation Center
  • Industry Expertise
    • Pharmaceuticals
      • Biosimilar Consulting
    • Medical Devices
    • Biologics
    • Biosimilars
      • Biosimilar Video
  • Regulatory Expertise
  • Market Access Expertise
  • Global Presence
    • North America
    • South America
    • Europe
    • Asia
    • Middle East & Africa
    • Emerging Markets
  • Digital Transformation
  • Strategic Partnerships
  • ExecuPharm Functional Service Solutions
  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
  • Home
  • Journey
    • Planning
    • Phase I
    • Phase IIa
    • Phase II-III
    • Phase IIIb-IV
    • Post Launch
  • Solutions
    • PAREXEL® Biotech
    • Clinical Research
      • Early Phase Services
      • Phase II-III Services
      • Phase IIIb-IV
      • ForeSite™ Clinical Trial Methodology
      • Global Data Operations
      • Medical Writing Solutions
      • Quantitative Clinical Development Services
      • Clinical Trial Supplies & Logistics
      • Customer Care Services
      • Genomic Medicine Services
      • Clinical Adjudication Services
    • Informatics
      • Clinical Technology
      • Patient Technology
      • Regulatory Technology
      • Clinical Trial Supplies & Logistics
      • Asset Transfer Services
      • PAREXEL's Education Services
      • Customer Care Services
    • Regulatory
      • Regulatory Strategy & Development Planning
      • Regulatory GMP Compliance
      • Regulatory Partnerships
      • Clinical Trial Regulatory Services
      • China Advisory Services
      • IDMP Solutions
    • Access
      • Real World Evidence
      • Drug Safety Services
      • Market Access Consulting
      • Medical Communications
      • Outsourced Field-Based Medical Teams
  • Experience
    • Therapeutic Expertise
      • Oncology
      • Cardiovascular & Metabolic Diseases
      • Central Nervous System (CNS) Disorders
      • Infectious Disease
      • Respiratory Capabilities
      • Rheumatology & Immunology Capabilities
      • Rare Diseases
    • Patient Innovation Center
    • Industry Expertise
      • Pharmaceuticals
      • Medical Devices
      • Biologics
      • Biosimilars
    • Regulatory Expertise
    • Market Access Expertise
    • Global Presence
      • North America
      • South America
      • Europe
      • Asia
      • Middle East & Africa
      • Emerging Markets
    • Digital Transformation
  • Outsourcing Models
    • Strategic Partnerships
    • ExecuPharm Functional Service Solutions
  • Company
    • Management Team
      • Jamie Macdonald
      • Peyton Howell
      • Greg Rush
      • Michael Crowley
      • Michele Fournier
      • Sy Pretorius, M.D.
      • Gadi Saarony
    • News & Events
      • Press Releases
      • Events
      • Webinars
      • 12th Annual Partnerships in Clinical Trials Congress
      • Archived PAREXEL in the News
    • Find an Office
    • Careers
      • Careers at PAREXEL®
      • CEO Message
      • Find Your Path - Opportunities
      • University Graduates – Opportunities for students
    • Volunteer
      • About Us
      • Locations Worldwide
      • About Clinical Trials
      • Why Participate?
      • FAQs
      • Glossary
    • Sustainability
      • Consumption Trend Analysis
    • Code of Conduct
    • eClinical Innovation
    • Purchasing
      • Purchase Order Terms and Conditions
      • Bedingungen für den Kaufauftrag
      • Vigente desde el
      • PO Terms - Japanese
      • PO Terms - Chinese 'S'
      • PO Terms - Chinese 'T'
      • Ordem de Compra Termos e Condições
    • Contact Us
      • Thank You
    • Partners
      • Service Partners
      • Training Partners
      • Technology Partners
      • Referral Partners
      • Accredited Partner Program
    • PAREXEL Reports U.K. Gender Pay Data
    • Tax Strategy
    • Brexit Statement
  • Perceptive®
  • User Group Meeting
    • IMPACT CTMS User Group Meeting Details and Agendas
    • IMPACT CTMS User Group Meeting Justification Letter
    • Meeting Registration and Hotel Details
    • Benefits for attending the IMPACT CTMS User Group Meeting
    • Registration Rates
    • Hotel Rates
  • Horizons
    • Agenda
    • Venue/Location
    • FAQs
    • Speakers
  • RWE Symposia
    • About
    • Locations
    • FAQs
    • Agenda
  • Graduate | PAREXEL
    • Culture at PAREXEL
    • Former Trainees at PAREXEL
      • Career Trainee Meghan
      • Career Trainee Sam
    • Great Place to Work
    • PAREXEL Overview
    • Clinical Trainee Program Belgium
    • Clinical Trainee Program Japan
    • Graduate Scheme India
    • Clinical Research Awards
    • Graduate Scheme UK
  • parexel-insights
    • Precision Medicine’s Next Hurdle: Quality Management of Human Samples
    • Mergers & Acquisitions: Where’s the Real Finish Line?
    • Navigating Regulatory Submissions
    • Increasing Study Predictability
    • When It Comes to CTMS One Size Does Not Fit All
    • This Disease Will Not Win the Fight
    • WHAT CAN WE LEARN FROM IMMUNO-ONCOLOGY CLINICAL TRIALS?
    • A Biosimilar Milestone with Implications
    • Designing Trials Payers Can Trust
    • Recognizing Uncle David
    • RIM & IDMP Synergies
      • PAREXEL's Connected Journey™ of Data-Driven Services
    • High Performance Workplace Practices That Attract and Retain Millennials
    • Utilizing Secondary Healthcare Data Assets
    • Working Towards a Glimpse of a Cure
    • Clarifying the Criteria that Better Capture Antitumor Activity of Immune Therapeutics
    • Josh Schultz, Corp. VP Talks About PAREXEL Access
    • 'Now is the time to include Japan' says PAREXEL
    • Shogo Nakamori Discusses Trends in Drug Development in Japan
    • Dragons - the Guardians of Disease
    • New Approaches to Data Management in Clinical Trials
    • 30 Years Later: Lessons from Living in a Pandemic
    • Shogo Nakamori Discusses Joint Program for Clinical Research
    • Want Your Business to Thrive? Focus on Developing Your People
    • 3 Principles for a Sound Clinical and Regulatory Document Strategy for Small Biopharmaceuticals
    • Imaging Endpoint Selection For Biosimilar Development
    • CONSIDERATIONS IN BIOSIMILARS DEVELOPMENT– A US FDA PERSPECTIVE
    • Accelerated Pathways and Stock Prices
    • Leveraging the Cloud to Accelerate Time to Treatment
    • Developing Drugs in the New Era of Personalized Medicines
    • Clinical Trial Feasibility & Patient Enrollment: Differentiation Through Innovation
    • Interview with PAREXEL’s Aida Sabo, About Challenges & Successes in Diversity & Inclusion
    • Protocol Optimization
    • Why RTSM & IRT stand for Speed, Simplicity & Service
    • The Emerging Role of Wearable Devices For Real-World Data Collection
    • Shogo Nakamori Discusses Japan & Multi-national Trials
    • Demonstrating Value and Managing Risk Throughout Development
    • Grateful for Advancements in Medicine
    • Adaptive Trials: Complex But Advantageous
    • Quantitative Modeling For Clinical Trials
    • The Human Touch: Aligning Reward Systems with Company Strategy and Meaningful Work
    • Involved & Engaged: The Last Mile of Business Performance
    • Orphan Drug Pricing in Europe
    • Generating Evidence to Drive Patient Access
    • World Cancer Day: Breakthroughs and Challenges for Precision Medicine
    • Genomic Medicine, Data Modeling and Clinical Trials
    • PAREXEL’s Training Approach and the Importance of Training a Global Workforce
    • Rooting for Team Jessie
    • On Demand Webinar - The Power of Foresight: Improving Drug Development Performance through Optimized Protocol Design
    • "Yes, I Can!"
    • How to Simplify Site Tasks and Help Ensure Dispensing Accuracy
    • PAREXEL's Connected Journey™ of Data-Driven Services
    • Something Good Always Comes From Something Bad
    • Life is Short and Love is Eternal
    • Clinical Development of Next Generation Biologics
    • Medical Writing for Submission to Asia-Pacific Regulatory Authorities
    • The Collaborative Advantage of Biopharma Companies and Global Service Providers
    • Focused on the Finish Line
    • Three Skills Developers Will Need to Thrive in the New Era of Genomic Medicine
    • Surveillance or Surgery?
    • Accelerated Pathways & Commercial Consequences Forum & Findings
    • Using Analytics to Optimize The Clinical Development Process
    • Beyond Diversity: What Happens When You Define a Culture of Inclusion
    • The Complete Journey: Improving Clinical Trials Using Modern Technology
    • If You Never Stop Learning, You Can Never Stop Earning
    • Best Practices to Improve the IRT Site User Experience
    • A People Strategy Attracts the Best Talent
    • Navigating Regulatory Complexities Of Biosimilar Development
    • Contracting - A Key Component Of A Strong Vendor Relationship
    • Improving Site Experience with Risk-Based Monitoring
    • Accelerated Pathways: Global Opportunities & Challenges for Innovators
    • How do eClincal solutions Increase Clinical Trial Efficiency?
    • Immuno-Oncology: Past, Present and Future
    • Albert Liou Discusses the Drug Development Landscape in Korea
    • Training Compliance is an Increasingly Complex Journey
    • Successfully Integrating Electronic Health Record and Electronic Data Collection Data
    • PAREXEL Celebrates Women In STEM
    • The Next Generation of Talent Management: Opportunities For Diversity
    • The Clinical, Regulatory and Commercial Implications of Rapid Approval
    • How to Maximize Potential and Sidestep Pitfalls of MAPs
    • Running with a Purpose
    • The Evolution of Drug Development & Market Access via Connected Data-driven Solutions
    • Biosimilar mAbs – a unique and distinct market (for the time being…?)
    • World Cancer Day: Reflecting on Progress and Hope for Patients
    • Wearables Shaping the Future of Clinical Trials
    • Progress in Pursuit of a Cure - World AIDS Day 2017
    • Optimizing the clinical development process with Social, Mobile, Analytics, and Cloud (SMAC)
    • Three Keys To Mitigating Risk In Adaptive Trials
    • Get Into Pole Position with Modern IRT Services
    • Overcoming Data Capture and Management Challenges
    • How Protocol Optimization Improves Clinical Trial Outcomes
    • How Performance Reviews Support High-Performance Talent
    • Diversity and Inclusion: This Is How the Best Global Companies Learn, Plan, and Measure Success
    • The Impact of the Digital Human Resources Organization on People - Part 1
    • Data Management Roles, Process and Technologies in Risk Based Study Execution
    • Recorded Webinar: Getting to Approval Faster Through Technology Innovation
    • Attitude is Everything
    • What You Need To Know About Biosimilars Development
    • Why Strategy is Not Enough: Building the Bridge From Strategy to Results Requires Organizational Excellence
    • When the Doctor Becomes the Patient
    • Your clinical trial supply may be at risk – Brexit and the impact on IMP distribution
    • Dr. Sy Pretorius, Chief Scientific Officer Talks About Adaptive Design Trials
    • Drew Garty Discusses Data Driven Monitoring
    • Dream or Reality- Improving Patient Safety & Reducing Costs?
    • Innovation in the Pharmaceutical Industry: A Change Toward Personalized Medicine
    • Key Considerations In Biologics Clinical Development
    • Albert Siu, PhD, Explains How PAREXEL Academy Benefits Clients
    • How to Know You’re Keeping Your (Clinical Trial Supplies) Cool
    • Anything is Possible
    • Effective Late Stage Pathways For Biosimilar Products
    • The Life of a Human Biological Sample: A Look Inside and How to Maintain Its Integrity
    • You’re Hot Then You’re Cold -Temperature Management & RTSM Integration
    • Clinical Trial Support Query - Who Ya Gonna Call?
    • Aligning on Patient Outcomes – How Market Dynamics Can Facilitate RWD (Real World Data) Solutions in Research
    • Active Tracking Is Out To Reduce Sites’ Workload
    • Ubavka DeNoble Talks About PAREXEL's BioPharm Unit
    • The Journey Continues – I Got This
    • So, My Fitbit is Clinical Trial Grade Right?
    • Latin America’s Role in Clinical Studies
    • Trends in Translational Development
    • Effective use of Value to Achieve Optimal Market Access
    • Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development
    • HOW TO EFFECTIVELY DEVELOP CLINICAL DOCUMENTS IN THE EU/US AND CHINA NDA DOSSIER
    • The Art and Science of Productive FDA Meetings
    • Regulatory Strategy In Emerging Markets
    • Exploring Our Partnership with CHA Medical Group
    • PAREXEL Introduces Jamie Macdonald as Chief Executive Officer
    • Understanding different stakeholder requirements throughout commercialization
    • Development considerations: Comparing major markets including US, EU, Japan and China
    • Risk and Common Mistakes in Import and Export Documentation for Clinical Trials
    • Operational Aspects Of Independent Reviews for Immune-Oncology Clinical Endpoints
    • PAREXEL Academy Introduces New Collaboration to Develop Japan’s Biopharmaceutical Workforce of the Future
    • The Evolution of Randomization and Trial Supply Management Services
    • Exploring ways to enhance evidence generation & communication planning
    • FDA initiatives under 21st Century Cures Act
    • Seamless dataflow with a clinical Metadata Repository
    • PAREXEL Introduces Peyton Howell as Chief Commercial & Strategy Officer
    • Effective Regulatory Strategies for China Market Entry
    • Leveraging Imaging And Wearable Technology For Agile Trial Conduct
    • Increased Internal Collaboration is a Prerequisite for Improved Value Communication
    • Communicating Product Value for Success: Every Word Counts
    • Industry Experts Gather at PAREXEL for 2018 ISPE Investigational Products Community of Practice Symposium
    • Effective Strategies for Successful Global Development
    • Trends in Early Development
    • Understanding regulatory and payer requirements throughout commercialization
    • Interview: Greg Rush, Executive Vice President and Chief Financial Officer
    • Life of a Biosimilar
    • Improving Processes for Temperature Traceability from Packaging to Patient
    • Interview: Jason Martin, PAREXEL Corporate Vice President, Global Data Operations, and Travis May, Datavant co-founder and CEO
    • World Alzheimer’s Day: Reflecting on Progress and a Need for Collaboration Among Patients, Caregivers and the Drug Development Industry to Advance New Treatments
    • Improving Drug Development and Patient Access With the Right People, Processes, and Culture
    • PAREXEL Acknowledges World Cancer Day 2019
    • January Flurry: Our Regulatory experts share their perspective on a busy month at the FDA
    • Unlocking Drug Development Innovation with the Right People, Processes & Culture
  • agile-IRT
    • Agile IRT
    • Reduced Timelines
    • Simpler Processes
    • Expert Services
    • Contact
  • test
    • Graduate | PAREXEL
  • Menu
Home > parexel-insights > The Journey Continues – I Go...

The Journey Continues – I Got This

By Cindie Kazmer​
January 27, 2017

I have cancer - what a weighty statement. It feels heavy when I say it. It shocks people when they hear it. Some visibly recoil, most are stunned and speechless. Sometimes, you can see and hear hearts break. I am a private person, but it is foolish to think I can keep this a secret. Frequent appointments, and the after effects of chemotherapy will tell everyone anyway.

October 11, 2016, was both the best and the worst day of my life. On October 11, I was diagnosed with HER+, ER+ breast cancer. It is curable, but the treatment plan is a bit daunting requiring chemotherapy, surgery, and possibly other therapies as well. I am fortunate to have access to some of the best doctors in the world at Massachusetts General Hospital. I got this. It will just take a bit of time (and patience).

Why was it the best day? After I processed the shock, which still hits me at times, I know this journey will help me to always remember what is really important in life: family, friends, and making a difference in the world. I will always remember how precious life is, how important it is to appreciate those I love and the world we live in. Apparently, sometimes I need a shift kick to learn my life lessons.

I’ve always worked in healthcare, and I take great pride in making a positive difference to the diagnosis and treatment of illness. The nerd in me finds being on the other side fascinating, and I’ve rapidly gained a reputation amongst my doctors and nurses for asking ‘interesting questions’. One of the first things I did when I started chemotherapy was to look up which pharmaceutical companies are responsible for making me better, so I can thank them personally if the opportunity arises. I know that many of you were involved in bringing the therapies that will cure me to market – I can’t express how grateful I am, thank you!

I struggle to think of myself as a cancer patient – sometimes it just doesn’t compute. But, then I remember that I don’t have hair (which I hate beyond measure) and it comes back into sharp focus. I completed my first round of chemotherapy and have surgery scheduled in a few short weeks.

I am continually surprised and humbled by how supportive everyone is, quite unbelievable actually. I am grateful beyond words. I couldn’t do this alone and fortunately, I don’t have to. The journey continues – I got this.

Cindie Kazmer​ Senior Director, Logistics Solutions
Ask a Question

Share via

Related Articles

Topic

World Cancer Day

Linkedin Updates

View Profile

CAREERS AT PAREXEL®

If you are inspired to make a difference
in the world, we can help you make it possible.

Search job openings worldwide

PAREXEL International Corp.
+1 781 487 9900
195 West Street
Waltham, MA 02451 

  • ABOUT PAREXEL®
  • NEWS & EVENTS
  • VOLUNTEER
  • CONTACT
  • MY PAREXEL PREFERENCE CENTER
  • CLIENT LOGIN
  • LIQUENT®
  • CLINICAL TRIAL INVESTIGATOR
  • SITE MAP
  • TERMS OF SERVICE
  • PRIVACY POLICY
  • EU-U.S. AND SWISS-U.S. PRIVACY SHIELD NOTICE OF CERTIFICATION

Copyright ©2000-2019 PAREXEL International Corporation.